One of the early effects of Osteoarthritis (OA) is to break down the body’s synovial fluid, making it less effective. The major component in synovial fluid is hyaluronic acid, which is also the active component of TriVisc. TriVisc helps restore the synovial fluid to a more healthy state, thereby reducing the pain of OA.
TriVisc is supported by the most substantial clinical study of hyaluronic acids for knee osteoarthritis. Studies have demonstrated that five injections one week apart provide optimal pain relief, but each patient’s response may vary depending on the severity of their OA, degree of pain, and pre-existing medical conditions. For some patients, successful treatment may reduce pain within the first week after treatment begins. However, based upon clinical trials, most patients experience pain relief after their third injection of TriVisc given at weekly intervals.
In clinical studies, many patients receiving TriVisc therapy experience 6 months or more of pain relief. The treatment is FDA-approved and has been shown to be safe and effective, used worldwide over the past 20 years. Patients are advised to avoid strenuous activities such as jogging, tennis, and heavy lifting for at least 48 hours after receiving a TriVisc injection. Your healthcare provider will advise you about the level of activity that is right for you. Most patients are able to maintain their normal daily activities after receiving treatments.
Is TriVisc right for me?
TriVisc is approved for the treatment of knee pain due to Osteoarthritis of the knee in patients who do not get enough relief from simple over-the-counter pain medication or from exercise and physical therapy. You should discuss all of your current medications and vitamin supplements with your physician on a periodic basis.
Most insurance carriers and Medicare cover TriVisc. The process of obtaining reimbursement varies from plan to plan, so talk with us and your insurance provider before you begin treatment to find out if TriVisc is covered for you.
